MBiotech Program News
26/11/2012 - 09:38 -
Industrial Inroads: MBiotech program leading to impressive partnerships with industry.
Carla DeMarco
car.demarco@utoronto.ca
Eva Furczon has always found innovation in healthcare business very intellectually interesting. So with this pursuit as a driving force, coupled with her passion for forging new ways to facilitate access to innovative medicines, she enrolled in the University of Toronto Mississauga’s...
08/11/2012 - 18:00 -
2012 Symposium on Market Access in Diabetes
The MBiotech Class of 2013 will be presenting a Symposium on Market Access in Diabetes (SMAD) on November 8, 2012.
Date: November 8, 2012
Location: University of Toronto Mississauga
Instructional Building, Room 120
Refreshments: 6:00pm, Symposium: 6:30-9:30pm
Public market access for pharmaceuticals has become an increasingly...
05/10/2012 - 15:00 -
Biological markers increase clinical trial success rate of new breast cancer drugs
Lanna Crucefix
news.utm@utoronto.ca
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
“It...
18/09/2012 - 12:00 -
MBiotech alumnus publishes in The Journal of Rheumatology
MBiotech alumnus, Kavisha Jayasundara, co-publishes paper in The Journal of Rheumatology based on research conducted while an MBiotech student, under the supervision of Dr. Jayson Parker and in collaboration with Dr. Edward Keystone, Mount Sinai hospital. The paper provides, for the first time, a quantitative estimate for the risk of...
30/07/2012 - 11:30 -
Dr. Revers is taking a sabbatical
The Associate Director of the MBiotech Program, Leigh Revers, is currently on sabbatical. Read about his exploits in London on his My First Sabbatical daily blog.